Delete
Legend：
-
Phase Ⅲ
-
Phase II
-
Phase I
-
IND Enabling
-
PCC
TBD=Target to be disclosed.
-
Therapeutic AreaCandidateTargetIndicationMolecular FormClinical Phase
-
Endocrinology & Metabolism
Endocrinology & Metabolism-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci134GHR (Monthly)AGHD, PGHD, ISSFusion Protein (QM)Phase I
-
GenSci164PTH (Weekly)PTHPeptide Conjugate (QW)IND Enabling
-
GenSci155
IGF-1RAIS, BPD, sPIGHDPeptide Conjugate (QW)IND Enabling
-
-
Women’s Health
Women’s Health
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci074NK3RVMSSMPhase Ⅲ
-
GenSci142
GardnerellaBVLysinPhase I
-
GenSci161
IL1β*IL1αEMBsAbPhase I
-
-
Rheumatology
Rheumatology
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci120PD1-high T-cell depleterRAmAbPhase II
-
-
Dermatology
Dermatology
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci161
IL1β*IL1αHSBsAbPhase I
-
GS24-B058
IgE*TBDCSUBsAbPCC
-
GS25-B001
TL1A*TBD*TBDADTsAbPCC
-
GS25-B002
IL1α*TBD*TBDPsA, HSTsAbPCC
-
-
Gastroenterology
Gastroenterology
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GS24-B062
TL1A*α4β7*IL23IBDTsAbIND Enabling
-
-
Renal
Renal
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci144SLC6A19CKD, PKUSMIND Enabling
-
-
CNS
CNS
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci136APRIL*BAFFgMGFusion ProteinPhase I
-
GenSci155
IGF-1RAISPeptide Conjugate (QW)IND Enabling
-
GenSciP165
TfR-APP siRNAAlzheimer's DiseaseAntibody Oligonucleotide Conjugate (AOC)PCC
-
-
Respiratory
Respiratory
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci118
RAGECOPDsiRNA (inhaler)PCC
-
GenSci117
MMP7IPFsiRNA (inhaler)IND Enabling
-
GenSci111
CTGFIPFsiRNA (inhaler)IND Enabling
-
GenSci124
CFTRCFmRNA (inhaler)IND Enabling
-
GS24-B044
MUC5ACCOPD, BEsiRNA (inhaler)PCC
-
GS24-B063
TL1A*TBD*TBDAsthmaTsAbPCC
-
-
Ophthalmology
Ophthalmology
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci136APRIL*BAFFOMGFusion ProteinPhase I
-
GenSci098TSHRTED, GDmAbPhase I
-
GenSci148VEGF A/C/D *Ang2wAMDFusion ProteinIND Enabling
-
GenSci161
IL1β*IL1αNIUBsAbPhase I
-
GenSciP181TBDdAMDsiRNAPCC
-
-
Oncology
Oncology
-
CandidateTargetIndicationMolecular FormClinical Phase
-
GenSci143
PSMA*B7H3PCaBsAb Topo1i ADCPhase I
-
GenSci139
EGFR*HER2UCBsAb Topo1i ADCPhase I
-
GenSci140
FRα*FRαOCBiparatopic Topo1i ADCPhase I
-
GenSci128TP53 Y220CSolid TumorSMPhase I
-
GenSci145PI3KαBCSMPhase I
-
GenSci122KIF18AOCSMPhase I
-
GenSci180
CDH17*CEACRCBsAb Topo1i ADCIND Enabling
-
-
Endocrinology & Metabolism-
GenSci134
AGHD, PGHD, ISS
-
GenSci164
PTH
-
GenSci155
AIS, BPD, sPIGHD
-
-
Women’s Health-
GenSci074
VMS
-
GenSci142
BV
-
GenSci161
EM
-
-
Rheumatology-
GenSci120
RA
-
-
Dermatology-
GenSci161
HS
-
GS24-B058
CSU
-
GS25-B001
AD
-
GS25-B002
PsA, HS
-
-
Gastroenterology-
GS24-B062
IBD
-
-
Renal-
GenSci144
CKD, PKU
-
-
CNS-
GenSci136
gMG
-
GenSci155
AIS
-
GenSciP165
Alzheimer's Disease
-
-
Respiratory-
GenSci118
COPD
-
GenSci117
IPF
-
GenSci111
IPF
-
GenSci124
CF
-
GS24-B044
COPD, BE
-
GS24-B063
Asthma
-
-
Ophthalmology-
GenSci136
OMG
-
GenSci098
TED, GD
-
GenSci148
wAMD
-
GenSci161
NIU
-
GenSciP181
dAMD
-
-
Oncology-
GenSci143
PCa
-
GenSci139
UC
-
GenSci140
OC
-
GenSci128
Solid Tumor
-
GenSci145
BC
-
GenSci122
OC
-
GenSci180
CRC
-
